By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Drugs > Fecal microbiota, live (monograph) > Fecal Microbiota, Live Dosage
Drugs
https://themeditary.com/dosage-information/fecal-microbiota-live-dosage-5994.html

Fecal Microbiota, Live Dosage

Drug Detail:Fecal microbiota, live (monograph) (Rebyota)

Drug Class:

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Clostridial Infection

Usual dose: 150 mL rectally as a single dose

Comment:

  • This drug should be administered 24 to 72 hours following the last dose of antibiotics for Clostridioides difficile infection (CDI).

Use: Prevention of recurrence of CDI following antibiotic treatment for recurrent CDI.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Data not available

Precautions

CONTRAINDICATION:

  • Patients with a history of severe allergic reactions to any ingredient of this drug product.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Only for rectal administration.
  • Refer to manufacturer product information for detailed information on the recommended administration technique for this drug.

Storage requirements:
  • Original carton of the drug should be stored in an ultracold freezer at -60C to -90C (-76F to -130F).
  • This drug can be stored refrigerated at 2C to 8C (36F to 46F) for up to 5 days, including thawing time.
  • The administration set should be stored at 10C to 34C (50F to 93F). Do not freeze.

Reconstitution/preparation techniques:
  • Before administration, this drug should be thawed by refrigerating at 2C to 8C (36F to 46F) for 24 hours.
  • Alternatively, this drug can be kept refrigerated at 2C to 8C (36F to 46F) and used within 5 days, including thawing time.
  • Do not refreeze after thawing.
  • A heat source such as a microwave or hot water should not be used for thawing.
  • Refer to manufacturer product information for detailed information for preparation of this drug.

General:
  • This drug is not indicated for the treatment of CDI.
  • Properly dispose of the remnants of this product in medical waste.

Patient advice:
  • Patients should be informed that this drug is made from human fecal matter and may have food allergens.
  • Notify physician or healthcare professional if patient experiences persistent diarrhea (3 or more loose bowel movements within a 24-hour period for 2 consecutive days) following administration of this drug.
  • Do not take any oral antibiotic for 8 weeks following administration of this drug, unless directed by a physician.
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by